Results 231 to 240 of about 7,805 (301)

Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX‐SEMA 2.4 mg, an Italian real‐world study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate real‐world clinical use of semaglutide in obese patients, focusing on titration, tolerability and short‐term efficacy. Materials and Methods This retrospective study included obese patients treated with the weekly injectable semaglutide.
Simone Pampanelli   +12 more
wiley   +1 more source

Perspectives on Pertussis Prevention

open access: yes
Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Pre‐Treatment Concerns and Their Association With Functioning and Well‐Being During Incretin‐Based Therapy: A Cross‐Sectional Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim This study aims to examine weight‐loss history and pre‐treatment concerns, and their associations with current functioning and well‐being in adults undergoing incretin‐based pharmacotherapy for obesity. Materials and Methods This cross‐sectional study analysed 411 adults treated with three different incretin‐based medications. Demographics,
Ali Kapan   +4 more
wiley   +1 more source

Disseminated Visceral Varicella Presenting as Gastric Ulcers. [PDF]

open access: yesEur J Case Rep Intern Med
Sukmagautama C   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy